SESN2 and melanoma: Sesn2 promotes tumorigenesis and chemo-resistance under Ultraviolet B (UVB) stress and chemo-therapeutics by activating AKT in human squamous cell carcinomas (SCCs) and melanoma cells (Zhao et al., 2014).